Resources

3 Business Challenges from the CDMO’s Perspective

Felix Hsu, SVP and Global Head of WuXi Advanced Therapies and Erin Harris, Editor in Chief for Cell & Gene had a great conversation around the CDMOs perspective on manufacturing. Click to learn more about 3 Business Challenges from the CDMO’s Perspective. By Erin Harris, Editor-in-Chief of cellandgene.com Copyright © 1996-2019 VertMarkets, Inc. All Rights Reserved.

Resource Type: Publication
Resource Topic: Clinical & Commercial Manufacturing

VIEW

Validation of a PCR method for the detection of mycoplasmas according to European Pharmacopoeia section 2.6.7

Recent publication of a revised section for mycoplasma testing in the European Pharmacopoeia [1] has led to interest in validating a nucleic acid amplification technique (NAT) for use in detection of mycoplasma contaminants in biologics drugs. The replacement by or supplementation of the existing culture-based methods with a PCR-based method has several advantages for the …Read More >

Resource Type: Publication
Resource Topic: Laboratory Testing

VIEW